
In a recent survey, three-in-four respondents said they would prefer a once‑daily oral pill over a weekly injection of GLP-1s. So why aren't there more oral options? By David S. KimRead all our work, for free, at press.asimov.com.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Free AI-powered recaps of Asimov Press and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.